NOT-FD-16-005: Notice of Intent to Publish a Funding Opportunity Announcement for FDA Drug Residue Cooperative Agreement (U18)

Notice of Intent to Publish a Funding Opportunity Announcement for FDA Drug Residue Cooperative Agreement (U18)

Notice Number: NOT-FD-16-005

Key Dates
Release Date: March 3, 2016
Estimated Publication Date of Announcement: March 2016
First Estimated Application Due Date: May 2016
Earliest Estimated Award Date: September 2016
Earliest Estimated Start Date: September 2016

Related Announcements
None

Issued by
U.S. Food and Drug Administration (FDA)

Purpose

The U.S. Food and Drug Administration, Office of Regulatory Affairs, intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications for cooperative agreements to advance efforts to improve and develop state drug residue prevention programs. The FDA intends to provide assistance to promote the prevention of illegal drug residues in animal derived foods and to protect consumer exposure to drug residues in the edible products of food animals.

The proposed objective of FDA’s ORA cooperative agreement program is to develop, complement and enhance state drug residue prevention programs through educational outreach and training activities. Related activities may include and are not limited to the following:

develop materials needed to promote the prevention of illegal drug residues in animal derived foods
communicate and promote effective management practices for drug residue prevention
increase the knowledge of and compliance with approved drug use
extralabel drug use regulations and its prohibitions
understanding of treated animal management
measuring the performance of existing state drug residue prevention program
identifying areas of improvement and/or developing new programs
reduce the outcomes of illegal drug residues in animal derived foods
protect consumer exposure to drug residues in the edible products of food animals

This proposed opportunity may potentially be available to state government agencies that have current FDA tissue residue inspection contracts or have previously been awarded an FDA tissue residue inspection contract.

This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.

The FOA is expected to be published in March 2016 with an expected application due date in May 2016.

APPLICATIONS ARE NOT BEING SOLICITED AT THIS TIME.

Inquiries

Please direct all inquiries to:

Daniel Lukash
Email: daniel.lukash@fda.hhs.gov